- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Diabetomics covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (93), financial health (65), director (35) and company-foundation signals.
- Operating for 11+ years.
- Company status is Active as per MCA.
- Annual filings up to date (balance sheet as of Mar 2025).
- Loss-making in FY 2023.
- Positive net worth.
- 3 directors on the board.
- Director ANSHUMAN JAISWAL has DIN status "Deactivated due to non-filing of DIR-3 KYC".
About Diabetomics
Diabetomics is an MCA-registered Indian company: a Private Limited Indian Non-Government Company (CIN U24233TG2015PTC099351). Business overview includes Healthcare (Medical & Laboratory Equipment), incorporated on June 16, 2015 (11+ years old), headquartered in Medak, Telangana, India. The company is currently Active with Active Compliant compliance status.
- Location Plot No 26A And 26B, Muppireddipally,, Medak, Telangana - 502336
- Website diabetomics.in
Financial Performance of Diabetomics
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Diabetomics (3)
Charges of Diabetomics
| Lender | Amount | Status |
|---|---|---|
|
Others
Creation Date: 28 Mar 2017 |
5.00 cr | Closed |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Professional, Scientific and Technical | - | 100 |
| Professional, Scientific and Technical | - | 100.00 |
Flagged By Authority
Regulatory and exchange flags (preview)
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
